Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 14INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 931Neoplasms 613Breast Neoplasms 609Colorectal Neoplasms 459Neoplasm Metastasis 398Ovarian Neoplasms 330Melanoma 316Prostatic Neoplasms 315Lung Neoplasms 295Multiple Myeloma 293Recurrence 282Squamous Cell Carcinoma of Head and Neck 248Stomach Neoplasms 232Pancreatic Neoplasms 230Leukemia, Myeloid, Acute 224Triple Negative Breast Neoplasms 194Endometrial Neoplasms 190Carcinoma, Renal Cell 183Lymphoma, Non-Hodgkin 179Carcinoma, Hepatocellular 177Small Cell Lung Carcinoma 166Advanced Solid Tumors 158Leukemia, Lymphocytic, Chronic, B-Cell 157Lymphoma, Follicular 150Lymphoma, Large B-Cell, Diffuse 141Urinary Bladder Neoplasms 140Lymphoma 138Advanced Solid Tumor 137Uterine Cervical Neoplasms 135Head and Neck Neoplasms 134

Interventions

Observation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Lung Diseases, Interstitial × 1 year × Clear all
NCT06192004 2026-05-04

LOOP

AstraZeneca

Terminated
83 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Pneumonia, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡